GuideMark Opportunistic Equity Fund Institutional Shares (GIOEX)

12.92
Net Asset Value
+1.17%
1 Day
+4.53%
Year-to-Date
Overall Morningstar Rating
Large blend
Style or Category
No Load
Sales Expenses
1.03%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation over the long-term, with a secondary objective of current income. The fund will invest at least 80% of its assets in equity securities. Its portfolio is constructed by combining the investment styles and strategies of multiple sub-advisors. Each sub-advisor uses its own proprietary research and securities selection processes to manage a concentrated portfolio within its allocated portion of the fund's assets. The fund may invest up to 35% of its total assets in American Depositary Receipts ("ADRs") and securities of foreign companies in both developed or emerging market countries. It is non-diversified.

Performance

1 month-0.08% 3 years+18.28%
3 months+3.69% 5 years--
1 year+15.34% Since inception+13.17%
Data through --

Peer Comparisonvs. Large blend

 GIOEXCategory
Performance 5-yr return--+13.88%
Expense ratio1.03%1.14%
Risk 5 year sharpe ratio--1.07
Net assets$141.4M$3.9B
Average market cap$23.6B$102.1B
Average P/E18.518.1
Portfolio turnover59%59%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyGuideMark
Fund manager & tenureJohn Montgomery / 3 Years
Minimal initial investment$0.00
Minimum IRA investment--

Holdings

U.S. stock86.64%
International stock9.19%
Cash4.17%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AAPL Apple3.01%
MSFT Microsoft2.63%
-- 2.42%
WSH Willis Group Holdings PLC2.41%
WHR Whirlpool Corp2.09%
TEVA Teva Pharmaceutical2.08%
FOX Twenty-First Century Fox1.92%
JAH Jarden Corp1.89%
HUBG Hub Group Inc1.87%
BSX Boston Scientific Corp1.84%

To view my watchlist

Not a member yet?

Sign up now for a free account